Article
Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
Journal of clinical pharmacology - 1 Jan 1998
Frye R F, Adedoyin A, Mauro K, Matzke G R, Branch R A
Abstract excerpt
Chlorzoxazone is being developed and proposed for use as a probe to measure in vivo cytochrome P4502E1 activity, but the phenotypic trait measures that are used vary. Although the doses proposed for phenotyping range from 250 mg to 750 mg, the effect of dose on chlorzoxazone hydroxylation has not previously been evaluated. The purpose of this study was to characterize the pharmacokinetics of chlorzoxazone in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
